Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Critical Mineral Executive Order Issued by President Donald Trump (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Regulus Therapeutics Inc RGLS

Healthcare Biotechnology
Regulus Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing drugs targeting microRNAs to treat diseases with significant unmet medical need. The Company is focused on orphan kidney diseases where microRNA genetic drivers are implicated and there are clear unmet medical needs. Its product candidate, RGLS8429, an anti-miR next... see more

Current News (NDAQ:RGLS)

Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Updates

PR Newswire 12 days ago

Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference

PR Newswire March 4, 2025

Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

PR Newswire February 4, 2025

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)

PR Newswire January 29, 2025

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences

PR Newswire November 26, 2024

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates

PR Newswire November 7, 2024

Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

PR Newswire October 8, 2024

Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences

PR Newswire August 28, 2024

Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates

PR Newswire August 8, 2024
View More News ››

Opinion & Analysis (NDAQ:RGLS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RGLS)

Regulus Therapeutics Inc. (NASDAQ:RGLS): Navigating the Chal

http://beyondspx.com/2024/08/01/regulus-therapeutics-inc-nasdaqrgls-navigating-the-challenges-of-micro-rna-therapeutics/
MikeTester - August 1, 2024

RGLS ..... LMFAO ....right again ; )

N>H>O>D I sold too early..... All is good !
Iseneschal - September 12, 2022

RGLS ....move your $'s into.....

ACOR.... HSDT ; )  JMHO
Iseneschal - September 12, 2022

RGLS ..... I love money !

Sold all into the vol spike ...who knows what tomorrow may bring.  Have to bank when it's staring tou in the face   ...
Iseneschal - September 12, 2022

RGLS ..... A break of $2.45 will be meaningful

Cheers  The volume spiked as previously predicted ; )
Iseneschal - September 12, 2022

RGLS ..... N.H.O.D ; )

Now for a huge volume increase to vault this into the stratosphere ; ) JMHO
Iseneschal - September 12, 2022
View more Bullboard ››

Fiddlehead Resources Corp.

Fiddlehead Resources Corp.

Fiddlehead Resources Corp. is a TSXV listed Cardium-focused oil and gas producer with 1,750 boepd of low decline, high ...
View More »